UPSC CURRENT AFFAIRS – 22nd March 2025

Home UPSC Current Affairs India’s Bioeconomy: Fueling Innovation, Sustainability, and Inclusive Growth

India’s Bioeconomy: Fueling Innovation, Sustainability, and Inclusive Growth

Why in news?

In the 21st century, economies are no longer defined merely by industrial output or IT services. The emergence of the bioeconomy—an ecosystem built on the sustainable use of biological resources, science, and innovation—has given rise to a new paradigm of growth. India, with its rich biodiversity, scientific talent, and policy support, is rapidly transforming into a global biotechnology powerhouse, as reflected in the 16-fold growth of its bioeconomy from $10 billion in 2014 to $165.7 billion in 2024.

The Bioeconomy Defined

The bioeconomy encompasses sectors like biotechnology, bio-manufacturing, genomics, agriculture, healthcare, bioenergy, and environmental engineering. It represents the intersection of life sciences, digital innovation, and sustainability—a triad crucial for addressing some of the biggest challenges of our times: climate change, food security, healthcare access, and environmental degradation.

India’s Bioeconomic Leap: A Decade of Transformation

India’s India Bioeconomy Report 2025 underscores a silent revolution. Contributing 4.25% to the GDP, this sector has witnessed a CAGR of 17.9% over the last four years. The number of biotech startups has crossed 10,000, up from just 50 a decade ago. This rapid evolution is not accidental—it is the result of a vision-driven policy approach, scientific investment, and entrepreneurial energy.

Key milestones include:

Nafithromycin, India’s first indigenous antibiotic for respiratory diseases.
A successful gene therapy trial for hemophilia, showcasing leadership in precision medicine.
The Genome India Project, sequencing over 10,000 individuals across 99 communities.
BioSaarthi, a global mentorship initiative for biotech startups.
Collaboration with ISRO for space medicine research, essential for long-term astronaut health.

Policy as a Catalyst: The Role of BIO-E3 and BIRAC

India’s BIO-E3 Policy—focusing on Economy, Employment, and Environment—has brought together government, academia, and industry under one ambitious vision. With Assam becoming the first state to implement the framework, India is poised for decentralized biotech innovation.

Institutions like BIRAC (Biotechnology Industry Research Assistance Council) have played a pivotal role by funding innovations, enabling technology transfers, and fostering public-private partnerships. With Gross Expenditure on R&D (GERD) doubling from ₹60,196 crore in 2013–14 to ₹1.27 lakh crore in 2024, India’s commitment to science and innovation is stronger than ever.

Biotech for Bharat: Inclusive and Sustainable Growth

The true strength of India’s bioeconomy lies in its ability to drive inclusive growth:

Biofertilizers and biopesticides can revolutionize agriculture while reducing chemical dependencies.
Affordable diagnostics and vaccines can strengthen healthcare in rural and underserved regions.
Bioenergy and biodegradable materials can reduce the ecological footprint of industrial growth.

Biotechnology also holds the key to mitigating climate change, ensuring food security, and even preparing for future pandemics through biosurveillance and rapid vaccine development.

Challenges Ahead: The Roadblocks to Resolve

Despite impressive gains, India’s bioeconomy faces significant hurdles:

Regulatory bottlenecks that delay product approvals.
Weak industry-academia linkage in smaller states and regions.
Dependence on imported biotech equipment.
Lack of biotech literacy and skills at grassroots levels.
Need for stronger IPR frameworks and technology commercialization pathways.

To overcome these, India must strengthen translational research, build regional biotech clusters, promote bio-manufacturing sovereignty, and create a robust ecosystem of bioentrepreneurship with global linkages.

India's Global Role in the Biotech Century

India is not just a participant in the global biotech race—it is emerging as a leader. With initiatives such as One Health, Digital Health Mission, and its role in vaccine diplomacy during COVID-19, India has shown that its bioeconomy is both resilient and responsible.

As space medicine, synthetic biology, and bioinformatics gain traction, India’s deep talent pool and institutional maturity will be crucial in shaping global norms, standards, and ethical practices.

Conclusion

With strategic investment, a supportive policy ecosystem, and a vision of people-centric science, India’s bioeconomy is set to be a cornerstone of Aatmanirbhar Bharat, driving not only economic resilience but also health security, environmental sustainability, and global leadership in the decades to come.